Shimeng Zhang

949 total citations
36 papers, 765 citations indexed

About

Shimeng Zhang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shimeng Zhang has authored 36 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Oncology. Recurrent topics in Shimeng Zhang's work include Immune Cell Function and Interaction (7 papers), DNA Repair Mechanisms (6 papers) and Cancer-related molecular mechanisms research (5 papers). Shimeng Zhang is often cited by papers focused on Immune Cell Function and Interaction (7 papers), DNA Repair Mechanisms (6 papers) and Cancer-related molecular mechanisms research (5 papers). Shimeng Zhang collaborates with scholars based in China, United States and Czechia. Shimeng Zhang's co-authors include Ping‐Kun Zhou, Hua Guan, Weiqing Rang, Bo Huang, Xiaodan Liu, Qian Wang, Lei Zheng, Jinlan Huang, Xinru Mao and Fei Liu and has published in prestigious journals such as Nature Communications, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Shimeng Zhang

35 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shimeng Zhang China 17 456 180 162 151 88 36 765
Klara Valyi‐Nagy United States 20 466 1.0× 135 0.8× 157 1.0× 182 1.2× 146 1.7× 46 967
Emily N. Chin United States 13 484 1.1× 150 0.8× 197 1.2× 102 0.7× 54 0.6× 19 863
Hongxiang Liu China 14 1.1k 2.4× 104 0.6× 139 0.9× 156 1.0× 53 0.6× 26 1.3k
Ling Xie United States 21 1.1k 2.3× 183 1.0× 179 1.1× 316 2.1× 49 0.6× 48 1.4k
Linda Fong United States 7 764 1.7× 88 0.5× 210 1.3× 275 1.8× 73 0.8× 8 1.0k
Matilde Parreño Spain 16 561 1.2× 126 0.7× 97 0.6× 294 1.9× 32 0.4× 21 892
Osman Çen United States 14 233 0.5× 88 0.5× 183 1.1× 217 1.4× 91 1.0× 25 637
Natalie Grinshtein Canada 16 359 0.8× 95 0.5× 250 1.5× 284 1.9× 91 1.0× 23 850

Countries citing papers authored by Shimeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Shimeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimeng Zhang more than expected).

Fields of papers citing papers by Shimeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shimeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimeng Zhang. The network helps show where Shimeng Zhang may publish in the future.

Co-authorship network of co-authors of Shimeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shimeng Zhang. A scholar is included among the top collaborators of Shimeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shimeng Zhang. Shimeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Shimeng, Bingbing Yu, Chunjie Sheng, et al.. (2024). SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy. Advanced Science. 11(36). e2403019–e2403019. 13 indexed citations
3.
Zeng, Qi, Yao Chen, Shimeng Zhang, et al.. (2024). ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation. eLife. 13. 1 indexed citations
4.
Chen, Yao, Shimeng Zhang, Qibing Zeng, et al.. (2024). Targeting fibroblast activation protein with chimeric antigen receptor macrophages. Biochemical Pharmacology. 230(Pt 3). 116604–116604. 9 indexed citations
5.
Zhang, Shimeng, et al.. (2023). TRPM7 kinase activity induces amyloid-β degradation to reverse synaptic and cognitive deficits in mouse models of Alzheimer’s disease. Science Signaling. 16(793). eade6325–eade6325. 12 indexed citations
6.
Wang, Ziyang, Chen Yao, Zeng Qi, et al.. (2022). The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis. Frontiers in Microbiology. 13. 979904–979904. 3 indexed citations
7.
Zhu, Hong, et al.. (2020). Long Noncoding RNA LINC00963 Promotes CDC5L-Mediated Malignant Progression in Gastric Cancer. OncoTargets and Therapy. Volume 13. 12999–13013. 15 indexed citations
8.
Kong, Liang, Shimeng Zhang, Lu Zhang, et al.. (2020). <p>Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC</p>. International Journal of Nanomedicine. Volume 15. 6451–6468. 23 indexed citations
9.
Yu, Peng, Shimeng Zhang, Minyi Wu, & Yao Wang. (2018). Developing turns-amplitude clouds for healthy Chinese: reference values and influence factors. Chin J Neurol. 51(10). 824–830. 2 indexed citations
10.
Liu, Shuang, Shimeng Zhang, Rui-Jun Ju, et al.. (2017). Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma. European Journal of Pharmaceutical Sciences. 106. 185–197. 32 indexed citations
11.
Zhang, Shimeng, et al.. (2017). Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome. Biochemical and Biophysical Research Communications. 493(1). 821–826. 67 indexed citations
12.
Wen, Qian, Wenjing Xiong, Shimeng Zhang, et al.. (2016). Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell–cell interactions. Journal of Translational Medicine. 14(1). 41–41. 15 indexed citations
13.
Zheng, Hao, et al.. (2016). Involvement of upregulation of miR-210 in a rat epilepsy model. Neuropsychiatric Disease and Treatment. Volume 12. 1731–1737. 16 indexed citations
14.
Zhang, Shimeng, Fei Liu, Xinru Mao, et al.. (2015). Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells. International Journal of Oncology. 47(5). 1759–1766. 41 indexed citations
15.
Yuan, Shaopeng, Shimeng Zhang, Yuanyuan Zhuang, et al.. (2015). Interleukin-17 Stimulates STAT3-Mediated Endothelial Cell Activation for Neutrophil Recruitment. Cellular Physiology and Biochemistry. 36(6). 2340–2356. 55 indexed citations
16.
Zhang, Shimeng, He Zhang, Tianyi Yang, et al.. (2014). Interaction between HIV-1 Tat and DNA-PKcs modulates HIV transcription and class switch recombination. International Journal of Biological Sciences. 10(10). 1138–1149. 14 indexed citations
17.
Li, Hong, Zhangyong Ning, Wenbo Hao, et al.. (2012). Identification and characterization of monoclonal antibodies against the ORFV059 protein encoded by Orf virus. Virus Genes. 44(3). 429–440. 16 indexed citations
18.
Zhang, Shimeng, Maoyong Song, Tianyi Yang, et al.. (2012). HIV-1 Tat impairs cell cycle control by targeting the Tip60, Plk1 and cyclin B1 ternary complex. Cell Cycle. 11(6). 1217–1234. 30 indexed citations
19.
Wang, Hongyan, Shuang Liu, Shimeng Zhang, et al.. (2009). S-Phase Cells Are More Sensitive to High-Linear Energy Transfer Radiation. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1236–1241. 26 indexed citations
20.
Zheng, Hong, Zhiwu Chen, Lin Wang, et al.. (2007). Radioprotection of 4-hydroxy-3,5-dimethoxybenzaldehyde (VND3207) in culture cells is associated with minimizing DNA damage and activating Akt. European Journal of Pharmaceutical Sciences. 33(1). 52–59. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klara Valyi‐Nagy Breakdown of academic impact, for papers by Emily N. Chin Breakdown of academic impact, for papers by Hongxiang Liu Breakdown of academic impact, for papers by Ling Xie Breakdown of academic impact, for papers by Linda Fong Breakdown of academic impact, for papers by Matilde Parreño Breakdown of academic impact, for papers by Osman Çen Breakdown of academic impact, for papers by Natalie Grinshtein
Rankless by CCL
2026